Harbin Pharmaceutical Group

Harbin Pharmaceutical Group Co., Ltd. (SSE: 600664) is China's second-biggest drug maker by market value.[1] The major shareholder of the company was Chinese: 哈药集团有限公司 for 47.06% stake (as at 30 June 2016), literally have the same English name with the listed subsidiary, as the listed subsidiary missed the word "Joint-Stock / Shares" (Chinese: 股份) in its English official name.

Harbin Pharmaceutical Group Co., Ltd.
Simplified Chinese哈药集团股份有限公司
Traditional Chinese哈藥集團股份有限公司
Literal meaningHarbin Pharmaceutical Group, Company Limited by Shares

Business
Harbin Pharmaceutical Group Sixth Pharmaceutical Factory

Harbin Pharmaceutical is engaged in the research, development, manufacture and sale of pharmaceutical products. The Company primarily offers antibiotics, Chinese patent medicines, over-the-counter (OTC) medicines, healthcare products and synthesized preparations, among others.

During the year ended December 31, 2007, the Company obtained approximately 73% and 14% of its total revenue from the sale of western medicines and traditional Chinese medicines, respectively. As of December 31, 2007, the Company had two subsidiaries/associates: one specializes in manufacturing oral solutions, while the other is engaged in the retail and wholesale of pharmaceuticals.

gollark: That looks about the same.
gollark: You shouldn't *rely* on that, just implement AES in redstone or something.
gollark: Screenshot both of them?
gollark: One server I'm on actually does the rotation thing.
gollark: Alternatively, I secretly change my profile picture every hour to rotate it by 0.05 degrees, and that makes it do different things.

References
  1. Harbin Pharmaceutical to issue RMB 800 mln short-term bonds
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.